DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

CORONA Remedies Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 9 hrs ago·10 Aug 2026, 5:55 am

Corona Remedies

Corona Remedies Limited has informed exchanges about the schedule for its upcoming investor meet. This corporate event is a standard platform for the company to communicate directly with analysts and institutional investors.

For investors, these meetings are a key opportunity to gauge management sentiment and gather qualitative insights that are not always available in public filings. They often provide clarity on future growth strategies and operational outlooks.

Investors should watch for updates on the company’s guidance, product pipeline, and any commentary on the broader market environment during the interaction.